ADCs Targeting Embryonic Pluripotent Stem Cell Markers

In Americas, Antibodies by Karina KusovaLeave a Comment

Mike Schopperle of CureMeta joined us at Americas Antibody Congress 2016 to discuss ‘ADCs targeting embryoninc pluripotent stem cell markers’

Download this presentation to understand more about:

  • Main focus in cancer drug development: oncogenes
  • Common embryonic element present in all cancers
  • CureMeta’s product engine to generate high specificity and high affinity antibodies to embryonic targets.

and much more !

Get your copy here !

If you’re interested in learning more about ADCs and their targets, join us at Americas Antibody Congress 2017 , held May 23-24 in San Diego, CA . This event is co-located with World Biosimilar Congress USA and Cell Culture World Congress USA .

Learn more about Americas Antibody Congress

Leave a Comment

Current ye@r *